• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

Ranbaxy Laboratories Ltd

+ Add to Watchlist

RBXZF:US

7.2500 USD 0.4700 6.09%

As of 20:10:00 ET on 06/09/2014.

Price not available for RBXZF:US

Snapshot for Ranbaxy Laboratories Ltd (RBXZF)

Open: 7.2500 Day's Range: 7.2500 - 7.2500 Volume: 0
Previous Close: 7.7200 52wk Range: 4.3000 - 8.2000 1-Yr Rtn: -

Stock Chart for RBXZF

No chart data available.
  • RBXZF:US 7.2500
  • 1D
  • 1M
  • 1Y
7.7200
Interactive RBXZF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RBXZF

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 424.01
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.0391
Dividend Ex-Date 04/26/2011
5 Year Dividend Growth -
Next Earnings Announcement 07/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RBXZF

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for RBXZF

Ranbaxy Laboratories Limited manufactures and distributes a wide range of pharmaceutical products. The Company makes multisource antibiotics, analgesics, anti-inflammatory drugs and anti-ulcerant/gastrointestinal drugs such as "Roscillin" (Ampicillin), "Cifran" (Ciprofloxacin) and "Sporidex" (Cephalexin).

Arun SawhneyCEO/Managing DirectorIndrajit BanerjeePresident/CFO
Manjeet BindraChief Data Reliability OfficerRajiv GulatiPres:Global Pharmaceutical Bus
More Company Profile & Key Executives for RBXZF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil